Dear Editor
Metabolic syndrome (MetS) is a group of abnormalities characterized by central obesity, high triglycerides, hypertension or high normal blood pressure, low high-density lipoprotein (HDL) cholesterol, and diabetes or high fasting glucose. Subjects with this condition are at increased risk for developing diabetes mellitus and cardiovascular disease as well as increased mortality from other causes.1 The prevalence of MetS in the Iran, according to Isfahan Healthy Heart Program (IHHP), was 20.7% (men: 14.2%, women: 27.1%; P < 0.01), that in compassion of other Asian countries such as Turkey with 28.8% (men: 23.1%, women: 33.5%; P < 0.01),2 China with 13.8 % (men: 09.8%, women: 17.8%; P < 0.01),3 and India with 31.6% (men: 22.9%, women: 39.9%; P < 0.01),4 the prevalence of MetS in Iran is in moderate level.5-7 However, should bear in mind that the prevalence of MetS have an increasing trend, age increased in both gender.5 In Iran, According to the Iranian national census, elderly people have an increasing trend, so in 2006 in Iran, 7.26% of population were in age group of 60 years and older, and in 2011, elderly people included 8.19% of the population. However, with passage of time and increased life expectancy among Iranian population, we expect that observe increase in the prevalence of the MetS. According to IHHP in the center of Iran, the prevalence of MetS in people in age group of 60 years and older was 43.8 % (men: 31.5%, women: 56.5%; P < 0.01); and in under-60-years age group, the prevalence was 17.2% (men: 11.5%, women: 22.8%; P < 0.01). Based on this result, if Iranian policymakers of healthcare system do not take effective preliminary and primary prevention programs, the prevalence of the MetS in the next few decades will be very high in Iran. In Isfahan (one of industrial provinces of Iran), one community-based intervention (IHHP) launched form 2000 with the aim of lifestyle modification such as increasing physical activity, weight loss, improved diet, and quitting smoking; it seems that IHHP and similar intervention programs could improve people's lifestyle and be successful in halting or decreasing the slope of incidence of MetS.8
Footnotes
Conflicts of Interest
Authors have no conflict of interests.
REFERENCES
- 1.Godsland IF, Stevenson JC. Insulin resistance: Syndrome or tendency? Lancet. 1995;346(8967):100–3. doi: 10.1016/s0140-6736(95)92118-4. [DOI] [PubMed] [Google Scholar]
- 2.Gundogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: Evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009;7(5):427–34. doi: 10.1089/met.2008.0068. [DOI] [PubMed] [Google Scholar]
- 3.Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405. doi: 10.1016/S0140-6736(05)66375-1. [DOI] [PubMed] [Google Scholar]
- 4.Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K. Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol. 2004;97(2):257–61. doi: 10.1016/j.ijcard.2003.11.003. [DOI] [PubMed] [Google Scholar]
- 5.Sarrafzadegan N, Gharipour M, Sadeghi M, Khosravi AR, Tavassoli AA. Metabolic syndrome in Iranian elderly. ARYA Atheroscler. 2012;7(4):157–61. [PMC free article] [PubMed] [Google Scholar]
- 6.Gharipour M, Sadeghi M, Hosseini M, Andalib E, Boroujeni MB, Sarrafzadegan N. Effect of age on the phenotype of metabolic syndrome in developing country. Adv Biomed Res. 2015;4:103. doi: 10.4103/2277-9175.157796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gharipour M, Sarrafzadegan N, Sadeghi M, Khosravi A, Hoseini M, Khosravi-Boroujeni H, et al. The metabolic syndrome and associated lifestyle factors among the Iranian population. Adv Biomed Res. 2015;4:84. doi: 10.4103/2277-9175.156645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, Mohammadifard N, Rabiei K, Roohafza H, et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87(1):39–50. doi: 10.2471/BLT.07.049841. [DOI] [PMC free article] [PubMed] [Google Scholar]